[FETV=김현호 기자] Once again, a management dispute arose with Hanjin Group. This is because HYK Partners, a private equity fund manager, the second largest shareholder of Hanjin Co., Ltd., which is in charge of the group’s parcel delivery industry, aimed at Cho Hyun-min, vice president of Hanjin Co., Ltd. On the 22nd, Hanjin Co., Ltd. … Read more
[FETV=김창수 기자] Korea’s first COVID-19 antibody treatment,’Rekirona’, which was conditionally approved by the Ministry of Food and Drug Safety, will be supplied to medical institutions from the 17th. On the 17th, Hanmi Pharmaceutical made an internal announcement that one employee working at the 13th floor of the headquarters had been diagnosed with Corona 19 on … Read more
[FETV=김창수 기자] Remsima SC (ingredient name: Infliximab), a subcutaneous injection biopharmaceutical for the treatment of autoimmune diseases, sold (directly sold) by Celltrion Healthcare, started to expand sales in Europe as the first prescription was made in France. Celltrion Healthcare, after launching’Remsima SC’ in France earlier this month, hosted a’Remsima SC Launch Online Press Conference’ on … Read more
[FETV=김윤섭 기자] This year, pre-order sales for the Lunar New Year hit an all-time high thanks to premium gift sets. E-Mart and SSG.com announced on the 31st that, as a result of analyzing the sales of pre-booked gift sets for this year’s New Year, E-Mart and SSG.com increased by 53% and 97.1% compared to the … Read more